Navigation Links
Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
Date:11/6/2012

SAN FRANCISCO, Nov. 6, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2012 on Tuesday, November 13, 2012, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Thursday, December 13, 2012.

To access the conference call, follow these instructions:

Dial: (877) 881-2183  (U.S.); (970) 315-0453 (international)
Passcode: 50562038 (Nektar Therapeutics is the host)

An audio replay will also be available shortly following the call through Thursday, December 13, 2012 and can be accessed by dialing (855) 859-2056 (U.S.); or (404) 537-3406 (international) with a passcode of 50562038.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About Nektar
Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms.  Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide lic
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
2. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
3. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
4. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
5. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
6. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
9. Perrigo Company Announces Appointment Of New Board Of Directors Member
10. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
11. Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 TODAY, AEGATE, the leader ... announced the appointment of Peter Fox as ... Channels and Partner Officer. Peter has served ... its acquisition by Oracle in 2011. Prior ... Geneva and subsequently Convergys, a world renowned ...
(Date:12/19/2014)... RATON, Fla. , Dec. 19, 2014 ... into a multi-product agreement with MSN Laboratories Pvt. Ltd. ... and MSN expect to commercialize several new ANDAs.  Under ... and supply the products exclusively to Breckenridge for the ... products under its label.  Breckenridge and MSN have agreed ...
(Date:12/19/2014)... -- Monarch America Inc. (OTCQB: CANK) ("Monarch America" or the ... this review of the Company,s recent achievements and strategic ... this past year, we achieved many of our early ... say that Monarch America is in a stronger and ... stated Eric Hagen , CEO of Monarch America ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3
(Date:12/19/2014)... December 19, 2014 The ... to developing educational events, tools and resources for ... Cooking School , the world’s leading online cooking ... every human being needs: Culinary Rx. As an ... course, Culinary Rx, scheduled for debut spring 2015, ...
(Date:12/19/2014)... December 19, 2014 Eufaula, Oklahoma, located ... Lake Eufaula, the state’s largest lake with more than ... is home to a little more than 3,000 residents, ... on Saturday, the 6th of December. , Featuring Santa, ... through downtown Eufaula on Main Street. Narconon Arrowhead’s ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, ... respected cosmetic brand Juvéderm. Voluma XC treats volume loss ... Medspa at Hendrick is pleased to be able to ... to its clients. , Voluma is the first and ... treat the mid-face and cheek area. This non-invasive treatment ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- The intestinal bacteria ... and ulcerative colitis, may be inherited, researchers report. ... Medicine , could help in efforts to prevent the ... or colitis, the study authors added. "The intestinal ... young age can have a big impact on your ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- Injectable drug users ... the suicide attempt rate of other substance users, a ... is associated with the risk of suicide attempt and ... University of Montreal, said in a university news release. ... We wanted to know who among substance users were ...
Breaking Medicine News(10 mins):Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 2Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 3Health News:The Plantrician Project and the Rouxbe Cooking School Join Forces to Develop Culinary Rx – a Plant-Prescription Course 4Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2
... Offers Clinically Proven Effective Alternative to Controversial Over-the-Counter Cold ... common colds do not decrease as the ... of a new, naturally safe cold remedy, Zucol(TM) ( ... this prevalent virus, which actually strikes more during the ...
... see your full prescription medication history online and print ... tax season just around the corner, millions of Americans ... look for ways to get the most out of ... retail pharmacy, offers a simple way to get full ...
... MCA i1040XT, the new mobile clinical assistant (MCA), featuring touch screen ... and workflow of the clinical environment-- whether that is a hospital ... ... CA (PRWEB) March 4, 2009 -- TabletKiosk ®, a leader ...
... taking supplements often exceed recommended levels, study finds , , ... older Americans aren,t getting enough micronutrients such as calcium, ... an important role in maintaining health, a new study ... 6,200 people in four ethnic groups -- white, black, ...
... have also been accepted for publication as an original ... March 4 NewCardio, Inc. (OTC Bulletin Board: NWCI) ... Dr. Ihor Gussak, NewCardio,s Vice President and Chief Medical ... (ACC) 58th Annual Scientific Session in Orlando on March ...
... Calif., March 4 Based on its ... market, Frost & Sullivan presents OVATION Pharmaceuticals, ... & Sullivan Award for Entrepreneurial Company of ... success in achieving its growth objectives while ...
Cached Medicine News:Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 2Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 3Health News:Naturally Safe Zucol(TM) Brings Europe's Leading Cold Remedy to United States 4Health News:CVS/pharmacy Offers Free Prescription History Just in Time for Tax Season 2Health News:CVS/pharmacy Offers Free Prescription History Just in Time for Tax Season 3Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 2Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 3Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 4Health News:TabletKiosk Introduces the MediSlate™ MCA i1040XT: A Mobile Clinical Assistant (MCA) with Touch Screen Input 5Health News:Older Americans May Lack Adequate Nutrition 2Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 2Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 3Health News:NewCardio Leadership to Present Clinical Data of Fully Automated QTinno(TM) Study at American College of Cardiology Annual Meeting 4Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 2Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 3Health News:Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth 4
... a polypeptide hormone secreted in significant amounts ... placenta. Prolactin, in synergy with estrogen, plays ... and maintenance of mammary gland growth and ... may have effects on cell growth in ...
... This Enzyme-Linked Immunosorbent Assay (ELISA) serves ... (RBP) from plasma, serum and,urine. In a ... the samples is bound to an,available excess ... is,immobilized to the surface of the microtitre ...
... ADVIA Centaur delivers a ... It provides the flexibility to ... system, now and in the ... a comprehensive disease-focused menu of ...
The Elisa test is used for the detection and semi-quantitative determination of IgG, antibodies to myeloperoxidase in human sera as an aid to the diagnosis is of microscopic polyangiitis....
Medicine Products: